市场调查报告书
商品编码
1560965
2024-2032 年一次性医疗感测器市场报告(按产品类型、放置类型、应用、最终用户和地区划分)Disposable Medical Sensors Market Report by Product Type, Placement Type, Application, End User, and Region 2024-2032 |
2023年全球一次性医疗感测器市场IMARC Group达88亿美元。越来越多地采用护理点 (PoC) 和家庭诊断设备来监测术后復健和老年患者,以及医疗保健基础设施的不断改进,正在推动市场成长。
家庭病患监护的需求不断增长
对远端患者监测的需求日益增长,因为它允许医院和医生在传统诊所环境之外监测患者,这正在刺激一次性医疗感测器的市场份额。医疗保险和医疗补助服务中心 (CMS) 报告称,每年,病患监视器都会帮助个人避免再次入院。此外,采用远端监控的使用者报告,再入院率降低了 76%,患者满意度平均提高了 89%,总共节省了近 3.7 亿美元的医疗费用。因此,各种全球性和小型公司正在提供一次性医疗感测器,这是另一个重要的成长诱导因素。提供这些感测器的一些知名厂商包括 Smiths Medical 和 Mediaid。除此之外,製造商还推出了帮助患者在公共场所携带的医疗设备。例如,2020 年 7 月,BioIntelliSense 和飞利浦建立了策略合作伙伴关係,以加强对高风险个体的远端病患监测。此次合作使医生能够更轻鬆地关注在家中医院接受治疗的患者。
医疗感测器的不断进步
主要参与者专注于引入新技术,包括微机电系统(MEMS)感测器技术、癌症追踪感测器和光纤技术的开发,这反过来又刺激了一次性医疗感测器市场的需求。除此之外,这些创新还透过简化设备的使用、提高生产力并方便患者改善健康状况来增强业务。例如,在 2021 年一次性医疗感测器市场中,OMNIVISION Technologies, Inc. 于 6 月推出了首款用于一次性和可重复使用内视镜的 800 万像素 (MP) 解析度感测器。同样,2022 年 4 月,Variohm EuroSensor 推出了一款 NTC 热敏电阻,专为医疗设备使用和感测医疗区域环境温度以及体内微小温度变化而设计。除此之外,2022 年 2 月,EnSilica 开发了 ENS62020,这是一种超低功耗医疗保健感测器接口,用于监测可穿戴医疗和保健设备中的生命体征。这些进步将在未来几年继续刺激一次性医疗感测器的市场价格。
监管批准
新型一次性医疗感测器的发展可归因于政府机构监管批准数量的不断增加。例如,2020 年 7 月,生物感测器技术领域的知名企业 ivWatch, LLC 的 SmartTouchTM 一次性感测器获得美国食品和药物管理局 (FDA) 的许可,用于早期检测外渗和周边 IV 渗透事件。 FDA 的这项新许可扩大了 ivWatch 感测器产品组合,为输液中心、医院和其他医疗机构提供补充感测器解决方案,以提高患者安全并最大限度地降低与静脉注射治疗相关的风险。
The global disposable medical sensors market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. The increasing adoption of point-of-care (PoC) and at-home diagnostic devices to monitor post-operative rehabilitation and elderly patients, along with the continuous improvements in the healthcare infrastructures, are bolstering the market growth.
The Increasing Demand for In-Home Patient Monitoring
The increasing need for remote patient monitoring, as it allows hospitals and physicians to monitor patients outside of the conventional clinic setting, is stimulating the disposable medical sensors market share. The Centers for Medicare and Medicaid Services (CMS) reported that every year, patient monitors aid individuals in avoiding being readmitted to the hospital. Moreover, users who adopted remote monitoring reported a 76% reduction in readmission rates, an average of 89% patient satisfaction, and a total medical cost savings of nearly US$ 370 Million. Consequently, various global and small-scale companies are providing disposable medical sensors, which is acting as another significant growth-inducing factor. Some of the prominent players offering these sensors include Smiths Medical and Mediaid. Besides this, manufacturers are also introducing medical devices that help patients to carry even in public spaces. For example, in July 2020, BioIntelliSense and Philips entered into a strategic partnership to enhance remote patient monitoring for individuals at risk. The collaboration made it easier for doctors to keep an eye on patients who are being treated in hospitals at home.
Continuous Advancements in Medical Sensors
The key players are focusing on introducing novel technologies, including the development of micro-electro-mechanical systems (MEMS) sensor technology, cancer tracking sensors, and fiber optic technology, which, in turn, is catalyzing the disposable medical sensors market demand. In addition to this, these innovations enhance business by simplifying the use of the device, increasing productivity, and making it convenient for patients to improve their health. For example, in the disposable medical sensors market in 2021, the first 8-megapixel (MP) resolution sensors for single-use and reusable endoscopes were launched by OMNIVISION Technologies, Inc., in the month of June. Similarly, in April 2022, Variohm EuroSensor introduced a NTC thermistor, which was specifically designed for medical equipment use and sensing ambient medical area temperatures and small temperature changes in the body. Apart from this, in February 2022, EnSilica developed the ENS62020, an ultra-low-power healthcare sensor interface to monitor vital signs in wearable medical and healthcare devices. These advancements will continue to stimulate the disposable medical sensors market price in the coming years.
Regulatory Approvals
The development of novel disposable medical sensors can be attributed to the rising number of regulatory approvals by government bodies. For example, in July 2020, ivWatch, LLC, a prominent player in biosensor technology, received Food and Drug Administration (FDA) clearance for its SmartTouchTM disposable sensor for the early detection of extravasation and peripheral IV infiltration events. This new FDA clearance expanded the ivWatch sensor portfolio to provide infusion centers, hospitals, and other healthcare facilities with complementary sensor solutions to enhance patient safety and minimize the risks associated with IV therapy.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, placement type, application, and end user.
Biosensors currently exhibit a clear dominance in the market
The report has provided a detailed breakup and analysis of the market based on the product type. This includes biosensors, temperature sensors, pressure sensors, image sensors, accelerometers and patient position sensors, and others. According to the report, biosensors accounted for the largest market share.
A biosensor refers to a sensor that is utilized to detect the analyte. Some of the common types of biosensors available are potentiometric, conduct metric biosensors, electronic, blood glucose, thermometric, piezoelectric biosensors, etc. The growing need for performing faster diagnosis is expected to augment the market growth in this segment. For example, in May 2020, BioIntelliSense, Inc., a clinical intelligence and continuous health monitoring company, reported the advancement of its data-as-a-service (DaaS) platform and medical-grade biosensor product portfolio with the development of the BioButton device.
Currently, strip sensors hold the majority of the total market share
The report has provided a detailed breakup and analysis of the market based on the placement type. This includes wearable sensors, implantable sensors, ingestible sensors, invasive sensors, and strip sensors. According to the report, strip sensors accounted for the largest market share.
Strip sensors are generally adopted in disease testing, blood glucose monitoring, and magnetic nanoparticles. The strip sensors segment holds the largest market share on account of their widespread applications in diagnostics. Besides this, the emerging trend of self-diagnosis and the inflating popularity of home-based medical devices are bolstering the market growth in this segment.
Among these, diagnostics represent the largest market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes patient monitoring (continuous blood pressure monitoring, implantable loop recorder, cardiac monitoring electrode, pulse oximeter, smart pill, continuous blood glucose monitoring (CGM), and others), diagnostics (capsule endoscopes, HIV test strip sensors, pregnancy test strip sensors, drug and alcohol test strip sensors, and blood glucose test strip sensors), and therapeutics (insulin pump sensors, cardiac therapeutic electrode sensors, and cardiac catheter sensors). According to the report, diagnostics accounted for the largest market share.
The escalating demand for disposable medical sensors in a wide array of diagnostic devices, including spirometry, surgical tools, endoscopy, and medical imaging devices, is propelling the market growth in this segmentation. Apart from this, disposable medical sensors market overview indicates that the elevating occurrence of chronic diseases is inflating the need for diagnostics equipment. For example, in October 2020, Alifax S.r.l. and STMicroelectronics developed a quick and affordable portable solution to amplify genetic material (DNA1 and RNA) in patient samples for point-of-care molecular diagnostic detection by utilizing highly reliable Polymerase Chain Reactions (PCR) in real-time.
Currently, home care accounts for the majority of the total market share
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, home care, clinics, and diagnostic laboratories. According to the report, home care accounted for the largest market share.
The rising inclination towards remote patient monitoring is driving the overall market growth in this segmentation. Moreover, home care helps in minimizing the instances of hospital-acquired infections (HAIs) by adopting single-patient disposable medical sensors, thereby driving the market growth in this segmentation.
North America leads the market, accounting for the largest disposable medical sensors market share.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
Favorable reimbursement policies are one of the key factors driving the market growth in North America. Besides this, the inflating adoption of mobile surgery centers and the escalating demand for effective emergency care are also acting as significant growth-inducing factors. Additionally, continuous investments by venture capital firms to introduce advanced disposable medical device sensors are further positively influencing the regional market. For example, in May 2022, Nemaura Medical, Inc., a medical technology company focused on supporting personalized digital coaching programs and commercializing a daily disposable wearable glucose sensor, reported that it had secured US$ 5 Million in non-dilutive funding via a clean debt facility with no convertible elements or warrants. Apart from this, the inflating expenditure capacities of individuals in the United States are expected to catalyze the disposable medical sensors market in the coming years.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)